Genetic Differences in Dorsal Hippocampus Acetylcholinesterase Activity Predict Contextual Fear Learning Across Inbred Mouse Strains. by Mooney-Leber, Sean M et al.
The Jackson Laboratory 
The Mouseion at the JAXlibrary 
Faculty Research 2021 Faculty Research 
10-18-2021 
Genetic Differences in Dorsal Hippocampus Acetylcholinesterase 
Activity Predict Contextual Fear Learning Across Inbred Mouse 
Strains. 
Sean M Mooney-Leber 
Dana Zeid 
Prescilla Garcia-Trevizo 
Laurel R Seemiller 
Molly A. Bogue 
See next page for additional authors 
Follow this and additional works at: https://mouseion.jax.org/stfb2021 
 Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons 
Authors 
Sean M Mooney-Leber, Dana Zeid, Prescilla Garcia-Trevizo, Laurel R Seemiller, Molly A. Bogue, Stephen C. 
Grubb, Gary Peltz, and Thomas J Gould 
ORIGINAL RESEARCH
published: 18 October 2021
doi: 10.3389/fpsyt.2021.737897
Frontiers in Psychiatry | www.frontiersin.org 1 October 2021 | Volume 12 | Article 737897
Edited by:
Peter Kalivas,











This article was submitted to
Molecular Psychiatry,
a section of the journal
Frontiers in Psychiatry
Received: 08 July 2021
Accepted: 21 September 2021
Published: 18 October 2021
Citation:
Mooney-Leber SM, Zeid D,
Garcia-Trevizo P, Seemiller LR,
Bogue MA, Grubb SC, Peltz G and
Gould TJ (2021) Genetic Differences
in Dorsal Hippocampus
Acetylcholinesterase Activity Predict




Genetic Differences in Dorsal
Hippocampus Acetylcholinesterase
Activity Predict Contextual Fear
Learning Across Inbred Mouse
Strains
Sean M. Mooney-Leber 1, Dana Zeid 2, Prescilla Garcia-Trevizo 2, Laurel R. Seemiller 2,
Molly A. Bogue 3, Stephen C. Grubb 3, Gary Peltz 4 and Thomas J. Gould 2*
1Department of Psychology, University of Wisconsin-Stevens Point, Stevens Point, WI, United States, 2Department of
Biobehavioral Health, The Pennsylvania State University, State College, PA, United States, 3 The Jackson Laboratory, Bar
Harbor, ME, United States, 4Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University, Palo Alto,
CA, United States
Learning is a critical behavioral process that is influenced by many neurobiological
systems. We and others have reported that acetylcholinergic signaling plays a vital
role in learning capabilities, and it is especially important for contextual fear learning.
Since cholinergic signaling is affected by genetic background, we examined the
genetic relationship between activity levels of acetylcholinesterase (AChE), the primary
enzyme involved in the acetylcholine metabolism, and learning using a panel of 20
inbred mouse strains. We measured conditioned fear behavior and AChE activity in
the dorsal hippocampus, ventral hippocampus, and cerebellum. Acetylcholinesterase
activity varied among inbred mouse strains in all three brain regions, and there were
significant inter-strain differences in contextual and cued fear conditioning. There was
an inverse correlation between fear conditioning outcomes and AChE levels in the
dorsal hippocampus. In contrast, the ventral hippocampus and cerebellum AChE levels
were not correlated with fear conditioning outcomes. These findings strengthen the
link between acetylcholine activity in the dorsal hippocampus and learning, and they
also support the premise that the dorsal hippocampus and ventral hippocampus are
functionally discrete.
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INTRODUCTION
Learning is a complex behavioral process that relies on multiple neurobiological systems working
in concert. The cholinergic system is one such system whose signaling modulates learning and
memory networks (1, 2). For example, the acetylcholine muscarinic receptor (mAChR) antagonist
scopolamine has been shown to impair learning in a contextual fear conditioning task (3, 4), spatial
learning in the Morris Water Maze (5, 6), passive avoidance learning (6, 7), and object recognition
learning (8). Other work has found that signaling via nicotinic acetylcholine receptors (nAChR)
may modulate learning and memory.
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Signaling via nAChR systems can enhance learning through
interactions with other neurotransmitter systems. nAChR
antagonism with mecamylamine, a non-selective nAChR
ligand, does not impair fear conditioning (9, 10). However,
mecamylamine paired with a subthreshold dose of an NMDA
glutamate receptor antagonist disrupts fear conditioning (10).
NMDA receptor signaling acts upstream of synaptic plasticity
mediating several forms of learning and memory [for review see
(11)]. Results of NMDA receptor and nAChR co-antagonism
suggest that these two systems mediate similar learning-related
processes, with the nAChR system perhaps subordinate to
NMDA receptor signaling. In support, several studies have found
that the administration of nicotine (a nAChR agonist) enhances
learning (9, 12–14). In addition, nicotine reversed NMDA
receptor antagonism-induced deficits in fear conditioning,
and direct drug infusion experiments revealed that the dorsal
hippocampus mediated this effect (15). Other studies have
found that antagonism of nAChR receptors with mecamylamine
alone was sufficient to impair learning (6, 16). Importantly,
both of these studies used larger mecamylamine doses, and
other work suggests that mecamylamine may act as an NMDA
receptor antagonist at higher doses (17–19). Thus, impairment
of learning via mecamylamine at higher doses may represent its
influence on NMDA receptors directly instead of or in addition
to actions at nAChRs. In sum, the cholinergic system is involved
in learning, with the muscarinic subsystem directly mediating
learning-associated cell signaling and the nicotinic system
potentially interacting with glutamatergic signaling cascades to
modulate learning.
Acetylcholine, the endogenous ligand of mAChRs and
nAChRs, is primarily synthesized at axon terminals from choline
and acetyl coenzyme A by choline acetyltransferase (ChAT).
Acetylcholinesterase (AChE) works to rapidly metabolize
acetylcholine into acetate and choline in the synaptic space (20).
Manipulation of both acetylcholine synthesis and metabolism
can alter learning (21, 22). Prevention of acetylcholine
metabolism via AChE inhibition has been used to mitigate
cognitive impairments associated with many neurodegenerative
diseases (23–25).
A growing body of literature suggests that genetic variability in
AChE-related genes could influence learning. Single nucleotide
polymorphisms (SNP) in the ACHE gene, which encodes the
acetylcholinesterase enzyme, have been identified in humans
(26, 27). Valle et al. (28) reported that heritable variations in
the ACHE gene may underlie individual differences in AChE
expression and secretion. Genotype at a SNP found in the
ACHE gene also predicted responsivity to cognitive-enhancing
drug treatment in patients with dementia (29). Genetic variation
impacting cholinergic signaling and associated cognition has also
been reported in outbred and inbred rodent models (30, 31).
Matson et al. (32) found significant differences in AChE activity
in the brain cortex and red blood cells between 8 inbred mouse
strains. Further, Schwegler et al. (33) reported that the density of
cholinergic fibers within the hippocampus varied systematically
by genetic background, which correlated with learning outcomes
in two spatial learning tasks. Further evidence supporting the
role of AChE in learning has been documented elsewhere (34).
These findings support that the presence of genetic variants
related to cholinergic systems may have a measurable impact on
learning outcomes.
Inbred mouse strains provide a powerful tool for identifying
the genetic contributions to various behavioral outcomes since
each inbred strain has a fixed homozygous genome. Fear
conditioning is a simple form of learning that is often utilized
to study cognitive performance in rodent models. Studies
using large inbred mouse strain panels have demonstrated that
learning capabilities in components of fear conditioning are, in
part, driven by genetic background (35–37). Neuroanatomical
contributors to fear conditioning have been identified (38).
Specifically, the dorsal hippocampus is the primary processer
of contextual information during fear conditioning (39), but
it is not critically involved in cued fear conditioning (40).
These neuroanatomical divisions can be leveraged to assess
hippocampus-dependent and -independent learning in a fear
conditioning model. Since cholinergic signaling within the
hippocampus is vital for fear learning (4), genetic variation in
acetylcholine signaling could contribute to inter-strain variation
in fear conditioning.
Therefore, we examine genetic variability in AChE activity in
three brain regions (dorsal hippocampus, ventral hippocampus,
and cerebellum) in 20 inbred mouse strains. The dorsal and
ventral hippocampus were separately examined due to their
distinct roles in fear conditioning. Specifically, the dorsal
hippocampus is primarily involved in cognitive processing,
whereas the ventral hippocampus regulates stress and the
emotional response to fear (41). The cerebellum was selected as
a control due to its lack of participation in contextual or cued
fear conditioning (42). Contextual and cued fear conditioning
were used to understand how genetic variation in AChE activity
correlated with strain differences in hippocampus-dependent
learning. We hypothesized that learning capabilities and brain
AChE activity would vary significantly between strains; and
because of the prominent role that the hippocampus plays in
fear learning, we predicted that hippocampal AChE activity levels
would be correlated with fear conditioning.
METHODS
Subjects
Male 129S1/SvlmJ, 129S4/SvJaeJ, 129S8/SvEvNimrJ, A/J, AKR/J,
BALB/cJ, BTBRT<+>ltpr3<tf>/J, C3H/HeJ, C57BL/6J, CBA/J,
DBA/1J, DBA/2J, FVB/NJ, LP/J, MA/MyJ, NZB/BINJ, SJL/J,
SM/J, & SWR/J mice were obtained from Jackson Laboratory
(Bar Harbor, ME). 129S2/SvPasCrl were obtained from Charles
River (Wilmington, MA). Individual strain characteristics can
be found on https://mice.jax.org/ and https://www.criver.com/
(129S2). These mice were part of a larger project examining
the influence of genetic background on sensitivity to drugs of
abuse. All mice were 10–15 weeks of age for behavioral testing
and tissue collection (n = 9–13 per strain). All mice were
group-housed [with the exception of SJL/J, which were single-
housed due to excessive social aggression characteristic of this
strain; (43)] with a 12-h light/dark cycle and unlimited access
to food and water. All behavioral testing occurred between
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8:00A.M. and 5:00 P.M. All procedures were conducted in
accordance with the NIH Guide for the Care and Use of
Laboratory Animals and approved by the Penn State University
IACUC Committee.
Saline Exposure
As mentioned previously, mice from this study served as saline
controls for a larger project examining the impact of nicotine
on learning and memory. As a result of their experimental
assignment, mice used for the current study were exposed
to chronic saline for 12 days. Saline was administered via
subcutaneous osmotic minipumps (model #1002, Alzet Inc.;
Cupertino, CA, USA). Surgical implantation and removal of the
minipumps were performed under 3.5% isoflurane anesthesia
using aseptic procedures. Pumps were removed 1 day prior to
behavioral training.
Apparatus
Fear conditioning training and testing for contextual fear
learning occurred in four identical noise-attenuating chambers
with metal bar grid flooring (18.8 × 20 × 18.3 cm, MED
Associates, St. Albans, VT, USA). Testing for cued fear
learning was conducted in a separate room in four identical
noise-attenuating chambers (20.32 × 22.86 × 17.78 cm, MED
Associates, St. Albans, VT, USA) designed to have distinct
sensory cues (different chamber size, solid plastic flooring,
background vanilla odor) to allow subjects to distinguish them
from the training/context test chambers. Both sets of chambers
were equipped with side-mounted speakers for cued stimuli
presentation (85 dB white noise) and fans to provide ventilation
and background noise (65 dB). Freezing behavior was recorded
using cameras mounted to chamber ceilings (Ikegami, Tokyo,
Japan) connected to Noldus media recording software (Noldus,
Wageningen, Netherlands). Stimuli presentation during training
and both testing sessions was controlled byMed-PC software and
hardware (MED Associates, St. Albans, VT, USA).
Fear Conditioning
Mice were trained and tested in both contextual and cued fear
conditioning, as previously established in our laboratory (37).
Briefly, for training, mice were placed in an operant chamber for a
total of 5min. The first 2min of training consisted of a stimulus-
free period (baseline) followed by 2 conditioned stimulus (CS; 30-
s 85 dB white noise)—unconditioned stimulus (US; 2-s 0.45mA
foot shock) pairings presented 2min apart, in which the US
overlapped with the last 2-s of the CS. The 2-min period in
between the two CS-US pairings served as the immediate or post-
shock period. Two associations are formed during the training
trial and are used to assess fear conditioning: (1) Between the tone
CS and footshock US (cued fear conditioning) and (2) Between
the footshock US and the context/environment (contextual fear
conditioning). To assess the strength of these unique forms of
learning and memory, mice were tested for both contextual and
cued learning 24 h after training. To test contextual fear learning,
mice were placed back inside the training chamber over a 5-min
trial with no stimulus presentation. Cued testing occurred at least
1 h after context testing, for which mice were placed in a novel
chamber for a 3-min baseline assessment (pre-cue), followed by
3-min of CS exposure (cued). Chambers used for context and
cued testing were not counterbalanced to be consistent with
previous studies examining the impact of nicotine withdrawal
on fear learning (37) and because contextual fear learning was
the primary focus on this study. Novel cues (plastic flooring
and vanilla scent) were present during cued testing to minimize
generalization to the training chambers. All sessions were video
recorded. Freezing behavior was tracked during all sessions via
EthoVision XT (Noldus, Wageningen, Netherlands).
Tissue Collection and AChE Activity
Twenty-four hours following the fear conditioning test, mice
were sacrificed for the collection of hippocampus and whole
cerebellum. Hippocampi were further dissected into dorsal and
ventral sections (1:1 ratio). All tissue was flash frozen on dry
ice and stored at −80
◦
C until further processing. Brain tissue
from 5 to 6 mice was randomly selected from each strain. Tissue
was homogenized in 1X RIPA buffer solution (R0278, Sigma
Life Sciences, St. Louis, MO, USA) with HALT Protease and
Phosphatase Inhibitor Cocktail at a ratio of 100:1 (78445, Fisher
Scientific, Pittsburgh, PA, USA). Homogenates were spun down
at 14,000 g at 4◦C for 30min. Total protein concentration of the
supernatant was determined by DC Protein Assay (500-0112;
Bio-Rad, Hercules, CA, USA). Each supernatant sample was
further diluted in RIPA buffer to a standard 30 µg total protein.
AChE activity in diluted samples was measured using the Abcam
Acetylcholinesterase Assay Kit (ab138871, Abcam, Cambridge,
MA, USA) per manufacturer instructions. Inter- and intra-assay
duplicate CV% were all <15%.
Mouse Phenome Database Gene
Polymorphism Queries
To assess sequence variation in genes encoding AChE and other
proteins relevant to cholinergic signaling, genes were surveyed
using the Mouse Phenome Database SNP data retrieval tool
(44). SNP and indel data were retrieved from the Sanger4 (45)
data set because of its extensive genome coverage. However,
only a subset of 13 strains was analyzed (DBA/1J, C57BL/6J,
LP/J, BALB/cJ, DBA/2J, 129S1/SvImJ, CBA/J, C3H/HeJ, A/J,
AKR/J, NZB/BINJ, FVB/NJ, BTBR T+ Itpr3tf/J) due to the other
strains not being represented in the Sanger4 data set. These
data were compiled with gene function and length data from
Mouse Genome Informatics website [http://www.informatics.
jax.org/index.shtml (June, 2021)] in Supplementary File 1.
Heritability Estimates and Behavioral
Correlations
Heritability estimates were based on within- and between-
strain variance produced from one-way ANOVAs for each
behavioral and biological outcome. Briefly, sum of squares
between strains (between strain variance) was divided by the
summation of sum of squares between and within-strains [within
strain variance; (46)]. To explore potential genetic overlap
between the collected behavioral and biological variables, strain
mean Pearson r correlations between all fear conditioning and
AChE activity variables were computed. Pearson r correlations
Frontiers in Psychiatry | www.frontiersin.org 3 October 2021 | Volume 12 | Article 737897
Mooney-Leber et al. Genetic Differences Learning and Acetylcholinesterase
were also computed between AChE activity strain means
and other behavioral phenotypes available through a custom
dataset within Mouse Phenome Database [fear conditioning
(Mooney1) and AChE data (Mooney2) collected for this
study are available at https://phenome.jax.org]. A significance
threshold of p < 0.01 (based on Pearson r) was applied to
correlations calculated for AChE activity strain means in each
brain region. As we were specifically interested in behavioral
outcomes related to AChE activity, correlations significant at
p < 0.01 derived from behavioral assays are highlighted (see
Supplementary Tables 1–3).
Statistical Analysis
Separate one-way ANOVAs with strain as a between-subjects
factor were utilized to examine conditioning variables (baseline,
immediate, context, pre-cue, & cued freezing) and brain AChE
activity levels (dorsal hippocampus, ventral hippocampus, and
cerebellum). ANOVAs with a significant effect of strain were
followed up with Tukey HSD post-hoc. If Levene’s test of
homogeneity of variance was violated, a Games-Howell post-hoc
was conducted instead. Associations between fear conditioning
behaviors and AChE activity were examined using a Pearson r
correlation coefficient. All data analyses were conducted using
SPSS 26 software (IBM, Chicago, USA). ANOVA results and
within-dataset correlations were considered significant at p <
0.05. Strain AChE mean correlations with Mouse Phenome
Database behavioral datasets were considered significant at p <
0.01. The significance threshold of p < 0.01 was selected as a
compromise between statistical lenience and stringency (47) to
match the exploratory nature of these analyses.
RESULTS
Fear Conditioning
We examined multiple behavioral components of fear
conditioning in 20 inbred strains. The range of freezing
responses varied based on the following behaviors: baseline
0.48–19.15%, immediate 0.27–55.61%, context 6.96–77.18%,
pre-cue 2.93–46.3%, and cued 21.54–84.14%. The resulting
data was analyzed using one-way ANOVAs for the following:
freezing during the baseline phase of fear conditioning training
[Figure 1A; F(19,193) = 12.81, p < 0.001], freezing during the
immediate (post-shock) phase [Figure 1B; F(19,193) = 20.27,
p < 0.001], freezing to the conditioned context [Figure 1C;
F(19,193) = 33.12, p < 0.001], pre-cue freezing during the cued
fear learning test [Figure 1D; F(19,193) = 13.19, p < 0.001],
and freezing to the conditioned cue [Figure 1E; F(19,193) =
18.85, p < 0.001]. Each ANOVA revealed a significant main
effect of strain. The calculated genetic heritability for freezing
in each of these stages of fear conditioning were: baseline
freezing 57.36%, immediate freezing 67.45%, context freezing
76.32%, pre-cue freezing 58.18%, and cued freezing 66.04%.
Post-hoc outcomes examining strain differences can be found in
Supplementary Tables 4–8.
AChE Activity
We examined dorsal and ventral hippocampal and cerebellum
AChE activity in 20 inbred strains. The range of AChE activity
levels varied by region: dorsal hippocampus 201.2–271.3 mU/ml,
ventral hippocampus 222.5–325.1 mU/ml, and cerebellum 187–
273 mU/ml. The resulting data was analyzed using separate one-
way ANOVAs for dorsal hippocampus AChE activity [Figure 2A;
F(19,99) = 2.37, p = 0.003], ventral hippocampus AChE activity
[Figure 2B; F(19,100) = 4.25, p < 0.001] and whole cerebellum
AChE activity [Figure 2C; F(19,99) = 1.81, p = 0.032], which
found a significant main effect for strain. Genetic heritability
estimates were calculated as follows: dorsal hippocampus AChE
activity 34.43%, ventral AChE activity 45.24%, and cerebellum
AChE activity 26.15%. Post-hoc outcomes examining strain
differences can be found in Supplementary Tables 9–11.
Mouse Phenome Database Gene
Polymorphism Queries
To identify genetic variants that could underlie the observed
inter-strain differences in AChE activity and learning, we used
the Mouse Phenome Database SNP data retrieval tool to
examine inter-strain allelic differences in 28 genes related to
cholinergic signaling. Their functions and SNPs are listed in
Supplementary File 1. Notably, there were 18 polymorphisms
within the AChE gene, including 5 indels. There were also many
polymorphisms in other cholinergic signaling genes.
Within-Dataset AChE Activity and Fear
Conditioning Correlations
To examine potential genetic overlap between behavioral
components of fear conditioning, strain mean correlations were
calculated between all measured fear conditioning variables
(Table 1). Freezing during the baseline of fear conditioning
training positively correlated with immediate (post-shock)
freezing during training [r(18) = 0.87, p < 0.001], freezing to
the conditioned context [r(18) = 0.70, p = 0.001], and pre-cue
[r(18) = 0.73, p < 0.001] freezing, but not with freezing to the
conditioned cue. Immediate (post-shock) freezing also positively
correlated with freezing to context [r(18) = 0.69, p = 0.001], pre-
cue freezing during the cued fear learning test [r(18) = 0.79, p
< 0.001] and freezing to cue [r(18) = 0.53, p = 0.016]. Context
freezing also positively correlated with pre-cue freezing [r(18)
= 0.93, p < 0.001] and cue freezing [r(18) = 0.54, p = 0.013]
freezing. Finally, pre-cue freezing also correlated positively with
cue freezing [r(18) = 0.60, p = 0.005]. These results may point
to shared genetic variance underlying freezing during different
stages of fear conditioning.
Strain mean correlations were similarly calculated for AChE
activity between brain regions (Table 1). From the three brain
regions examined, only a positive correlation between dorsal
and ventral hippocampus AChE activity levels was found
[r(18) = 0.52, p = 0.019]. Dorsal and ventral hippocampus
AChE activity did not significantly correlate with cerebellum
AChE activity. Significant covariance between dorsal and ventral
hippocampus AChE activity implies potentially shared genetic
factors impacting AChE activity levels between functionally
distinct regions of the hippocampus.
Finally, we examined the relationship between strain means
for brain AChE activity and freezing during fear conditioning.
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FIGURE 1 | Significant strain differences were present for all fear conditioning components. (A) Strain-dependent differences in baseline [F (19,193) = 12.81, p < 0.05],
(B) immediate [F (19,193) = 20.27, p < 0.05], (C) contextual [F (19,193) = 33.12, p < 0.05], (D) pre-cue [F (19,193) = 13.19, p < 0.05], and (E) cued [F (19,193) = 18.85, p <
0.05] freezing during fear conditioning. Data presented as mean ± SEM, n = 6–13 per strain. For post-hoc comparisons, please see Supplementary Materials.
Dorsal hippocampus AChE activity (Figure 3) negatively
correlated with immediate (post-shock) freezing during fear
conditioning training [Figure 3B; r(18) = −0.53, p = 0.016],
freezing to the conditioned context [Figure 3C; r(18) = −0.50,
p = 0.026], pre-cue freezing during cued test [Figure 3D;
r(18) = −0.58, p = 0.008] and freezing to the conditioned
cue [Figure 3E; r(18) = −0.54, p = 0.015] but not baseline
freezing (Figure 3A). No significant correlations between
ventral hippocampus or cerebellum AChE activity levels and
any of the measured fear conditioning variables were found
(Supplementary Figures 1, 2). Thus, genetic factors underlying
freezing during multiple stages of fear conditioning covary
exclusively with dorsal hippocampus AChE activity, despite
significant correlations between ventral and dorsal hippocampus
AChE activity.
Mouse Phenome Database Correlations
Brain AChE activity strain means were correlated with
publicly available phenotypes using the Mouse Phenome
Database. Only measures with mean data points for a
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FIGURE 2 | Acetylcholinesterase activity varies by strain. AChE activity (measured in mU/mL) showed a main effect of strain in the (A) dorsal hippocampus [F (19,99) =
2.37, p < 0.05), (B) ventral hippocampus [F (19,100) = 4.25, p < 0.05], and (C) cerebellum [F (19,99) = 1.81, p < 0.05] n = 8–11 per strain. Strains are shown from lower
to higher AChE activity levels in the dorsal hippocampus and then follow the same order in the ventral hippocampus and cerebellum graphs. For post-hoc
comparsions, please see Supplementary Materials.
TABLE 1 | Pearson correlation coefficients of AChE activity when correlated with different components of fear learning.
Baseline Immediate Context Pre-cue Cued DH AChE VH AChE CB AChE
Baseline 1
Immediate 0.87** 1
Context 0.70** 0.69** 1
Pre-CS 0.73** 0.79** 0.93** 1
Cued 0.43 0.53* 0.54* 0.6** 1
DH AChE −0.23 –0.53* –0.5* –0.58** –0.54* 1
VH AChE −0.02 −0.22 −0.09 −0.12 −0.14 0.52* 1
CB AChE 0.16 −0.02 0.41 0.35 −0.08 −0.17 0.09 1
*correlation is significant at 0.05 level; **correlation is significant at the 0.01 level (two-tailed), based on strain means.
Bold text represents significant values.
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FIGURE 3 | Acetylcholinesterase activity in the dorsal hippocampus correlates with different fear learning components. (A) Baseline freezing has a weak correlation (r
= −0.23, p > 0.05) with AChE activity in the dorsal hippocampus, whereas (B) immediate (r = –p < 0.05), (C) context (r = −0.50, p < 0.05), (D) pre-cue (r = −0.58,
p < 0.05), and (E) cued (r = −0.54, p < 0.05) freezing negatively correlate with AChE activity. Pearson correlations coefficients are presented in Table 1, n = 20 total
number of strains.
minimum of 8 strains overlapping with our own panel
were utilized for MPD correlation analysis. Two thousand
twenty-five total measures available in MPD were correlated
with AChE activity in each of the tested brain regions
(dorsal and ventral hippocampus and cerebellum). We made
the a priori decision to focus on the top ten significant
correlations of AChE with behavioral variables for the purpose of
this manuscript.
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For dorsal hippocampus AChE activity strain mean
correlations, 20 measures met the pre-determined significance
cut-off (p < 0.01; see Supplementary Table 1). Six of these
phenotypes were classified as behavioral models, and three were
cognitive assessments in the Barnes maze, as assessed by number
of errors that positively correlated with AChE activity. For ventral
hippocampus AChE activity (see Supplementary Table 2), 21
measures were considered to be significantly correlated (at p <
0.01), with ten of those phenotypes corresponding to a behavioral
measure. Specifically, for five out of the six correlated behaviors,
AChE activity correlated positively with emotional behavioral
responding in cued fear testing, light-dark box, and variants
of the elevated maze. Lastly, 30 measures met the significance
threshold for correlations with cerebellum AChE activity levels
(see Supplementary Table 3). Nine of these corresponded to
behavioral measurements. Of note, cerebellum AChE activity
correlated positively with six measures of scheduled operant
behavior, such as fixed-ratio responding.
DISCUSSION
Here we report significant variation in fear conditioning and
AChE activity in three brain regions across 20 inbred mouse
strains.We found that these phenotypes were heritable, especially
for freezing during the five stages of fear conditioning assessed
(baseline, immediate, context, pre-cue, & cued). Correlation data
generated within the current dataset indicate strong positive
genetic relationships between freezing levels in various stages
of fear conditioning and also between dorsal and ventral
hippocampus AChE activity, in addition to a negative correlation
between fear conditioning freezing and dorsal hippocampus
AChE activity. Correlations of our strain means with publicly
available datasets indicate that the dorsal hippocampus AChE
activity levels may be more closely related to learning
outcomes, whereas ventral hippocampus AChE activity may be
better associated with other emotional processing outcomes.
Collectively, these findings suggest a degree of heritability in
fear learning and hippocampal AChE activity levels and that
genetic variability associated with AChE activity in the dorsal
hippocampus may contribute to learning in fear conditioning.
AChE Activity
Using a panel of 20 inbred mouse strains, we found a
significant variation of AChE activity in the dorsal hippocampus,
ventral hippocampus, and cerebellum. These findings suggest
that AChE activity varies by genetic background. Our genetic
analysis identified at least 18 polymorphisms in the AChE
gene among a subset of the tested strains. Although these
polymorphisms did not clearly co-vary with learning or AChE
activity in the current panel, they likely contribute in part
to inbred strain variation in AChE efficiency and activity.
Importantly, enzymatic activity can be modulated by variation
in the enzyme itself (e.g., polymorphisms in the encoding
gene leading to altered protein structure and changes in
enzymatic activity), by distal regulatory genomic elements
(e.g., polymorphisms in trans-regulatory elements targeting
AChE gene expression), by interactions within the enzymatic
pathway (e.g., polymorphisms among broader genomic networks
involved in cholinergic signaling), or by a combination of these
factors. Our analysis found that related genes encoding choline
acetyltransferase (ChAT), an important enzyme in acetylcholine
synthesis (48, 49), RIC3, an acetylcholine receptor chaperone
protein (50, 51), butyrylcholinesterase, another acetylcholine-
metabolizing enzyme (52), and nicotinic acetylcholine receptor
subunits (53) also contain numerous polymorphisms across
strains. These polymorphisms could all potentially influence
cholinergic signaling and represent possiblemechanisms through
which genetic differences across strains influence AChE activity
and learning. Moreover, the large amount of cholinergic
modulating genes exhibiting polymorphisms suggests that the
observed phenotypic differences in learningmay involve complex
genotypic and regulatory interactions.
Fear Conditioning
The current results are in line with previous findings of
genetic variability in conditioned fear learning (37, 54, 55).
Analyses of our inbred mouse strain panel indicated significant
between-strain variation in freezing during multiple stages
of fear conditioning (baseline, immediate, context, pre-cue,
& cued). Moreover, these behaviors were highly heritable,
all demonstrating >57% heritability. Our fear conditioning
paradigm measured two distinct associations: First, between the
training context (contextual fear conditioning) and the US, and
second, between the CS and US (cued fear conditioning). Here,
we report a wide range of contextual fear conditioning across our
inbred strain panel with some strains demonstrating high (LP/J,
SM/J, 129S2, & 129S1, >68% freezing) and some demonstrating
low contextual fear conditioning (FVB/NJ, SWR/J, & BTBRT +,
<10% freezing). The differences in the mice that show high levels
of freezing and the mice that show low levels of freezing during
the context tests could suggest that the high and lower responders
differ in hippocampus-dependent learning. In support, studies
examining LP/J, SM/J, & 129S1 inbred mice have found high
levels of learning in hippocampus-dependent tasks (56) including
contextual fear conditioning (57, 58) relative to other tested
strains. Similarly, FVB/NJ, SWR/J, and BTBRT+ strains exhibit
low levels of hippocampus-dependent learning (35, 59–61). It
should be noted that FVB/NJ and SWR/J strains possess a
Pde6b gene mutation that leads to compromised visual acuity
(62). However, work conducted by Bolivar et al. (36) indicated
that retinal degeneration produced by this mutation did not
impact contextual fear learning. Moreover, the C3H/HeJ strain
shares a similar Pde6b mutation but displayed >20% freezing,
suggesting that factors outside of visual acuity contributed to
the observed strain differences. Interestingly, the three strains
with the lowest contextual fear learning also had the highest
levels of dorsal hippocampus AChE activity. Low contextual
fear conditioning in these strains may be explained in part by
higher dorsal hippocampus AChE activity levels (discussed more
below) as acetylcholine is critically involved in learning (63)
but other differences could also contribute to the differences in
fear conditioning.
In addition to contextual fear learning, we found significant
between-strain variation in cued fear conditioning. Our results
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indicate that the BTBRT+ strain exhibits poor cued fear
conditioning (∼21% freezing across trial), which is supported
by other studies (64). BTBRT+ strain displays abnormal
amygdala nuclei volume (65). Given the role of the amygdala
in cued fear conditioning (39), it is possible that structural
abnormalities within this region may account for the deficits
reported here.
Within-Dataset and Mouse Phenome
Database Correlations
Strain mean correlations are useful for identifying potential
relationships between the genetic influence of behavioral and
biological outcomes. Here, we found that dorsal hippocampus
AChE activity was significantly negatively correlated with
freezing in all stages of fear conditioning except for baseline
freezing. This finding suggests that genes that influence dorsal
hippocampus AChE activity may contribute to variability in fear
conditioning but not baseline levels of activity as assessed by
freezing. Dong et al. (66) reported significant improvement in
contextual fear conditioning in a mouse model of Alzheimer’s
disease following injections of AChE inhibitors physostigmine
or donepezil. Moreover, nicotine withdrawal- and MK-801-
induced deficits in contextual fear conditioning were prevented
after administration of an AChE inhibitor (67–69). Notably,
Csernansky et al. (67) observed inconsistent improvement in
contextual fear conditioning via inhibition of AChE in saline-
treated mice, suggesting that improvement in contextual fear
conditioning via inhibition of AChE may be dependent on
altered cholinergic signaling. The genetic association between
dorsal hippocampus AChE activity and learning was further
supported by our MPD analysis, which found that dorsal
AChE activity strain means were positively correlated with
the number of errors committed during the Barnes maze (see
Supplementary Table 1), a hippocampus-dependent learning
task. Qualitative support for this idea comes from the fact
that the bottom three strains with the lowest freezing to the
conditioned context (SWR/J, BTBRT+, and FVB/NJ) displayed
the highest dorsal hippocampus AChE activity, indicating
that enhanced AChE activity may impair contextual fear
learning. Alternatively, it is possible that genetic differences in
genes associated with AChE reflect or contribute to systemic
alterations in cholinergic function, which is critical for learning
(70, 71).
Both ventral hippocampus and cerebellum AChE activity
failed to correlate with fear conditioning variables. Previous
reports suggest that the dorsal and ventral hippocampus carry
out distinct behavioral functions despite being a continuous
anatomical structure (41). For instance, the dorsal hippocampus
plays a role in spatial learning and memory (72, 73), whereas
the ventral hippocampus is involved in emotional processing
and stress responding (74). Although we did not examine more
traditional behavioral paradigms of emotional processing (e.g.,
elevated plus maze or light dark box), strain mean correlations
with external datasets in MPD indicated significant associations
between ventral hippocampus AChE activity and behavioral
variables potentially representing emotional processing (see
Supplementary Table 2). Interestingly, higher AChE activity in
the ventral hippocampus was associated with greater frequency
of urination and fecal boli in the light-dark box and elevated
plus-maze. This suggests that increased AChE activity may
predict greater levels of anxiety. It is worth noting that fear
learning has emotional components and manipulation of ventral
hippocampus functioning can influence fear learning (75).
Moreover, recent findings from Giacomini et al. (76) suggest
that inhibition of AChE via donepezil increases anxiety-like
behavior in zebrafish in a dose-dependent manner. It is feasible
that overlapping genes mediate ventral hippocampus AChE
activity and anxiety-like behavior. However, the relationship
between anxiety and AChE activity in the ventral hippocampus
cannot be reliably surmised from the current data as there was
no significant correlation with fear conditioning. Traditional
measures of anxiety would need to be assessed to see if strain
variability in the ventral hippocampus contributed to altered
anxiety phenotypes.
Limitations/Conclusions
The current study’s goal was to examine genetic variation in
fear conditioning, as well as AChE activity in the hippocampus
and cerebellum. Our findings indicate that all five components
of fear conditioning and AChE activity in three brain regions
(dorsal and ventral hippocampus and cerebellum) significantly
differed based on genetic background. Additionally, strain
means correlational analysis found a negative relationship
between the dorsal hippocampus AChE activity and fear
conditioning, suggesting genetic variability in AChE activity
contributes to differences in learning. While these findings have
interesting implications for the role of AChE-related genetics in
learning it is important to highlight their correlational nature.
That is, the current study does not provide causal evidence
that AChE differences may or may not be due to genetic
differences. Future studies can also examine cholinergic markers
in regions such as the amygdala, which is also importantly
involved in fear conditioning (77). Additionally, correlations
with publicly available datasets are limited by the number
of overlapping strains. Moreover, it must be noted that all
animals in the current study underwent surgical procedures,
including osmotic minipump implantation (saline). Although
animals were not subjected to drug exposure, it is possible
that surgical stress may have influenced measured outcomes.
Lastly, the scope of the current study is limited by using
males only.
Collectively, our data provide further evidence that biological
and behavioral outcomes are influenced by genetic background.
Additionally, fear conditioning and dorsal hippocampus
cholinergic signaling appear to be associated and mediated by
common genetic factors. Additional research may help elucidate
potential genetic targets influencing fear conditioning and
AChE activity, as well as mechanisms possibly mediating the
relationship between dorsal hippocampus AChE activity and
fear conditioning.
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